Showing results (61-70 of 719) with videos related to
Sort By:
Pageof 72
Folia Biologica|January 5, 2001
Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term cultureB Schultheis, B Heissig, G Pasternak, et al.Mycoses|February 18, 2003
Pseudomembranous tracheobronchial aspergillosis: a rare manifestation of invasive aspergillosis in a non-neutropenic patient with Hodgkin's diseaseD Buchheidt, A Weiss, S Reiter, et al.Der Internist|December 16, 2003
[Chronic myeloproliferative diseases. Diagnosis and therapy]E Lengfelder, U Berger, A Reiter, et al.International Journal of Cancer|July 15, 1980
Time course of C-type retrovirus expression in mice submitted to osteosarcomagenic doses of 224radiumV Erfle, R Hehlmann, H Schetters, et al.Deutsche Medizinische Wochenschrift (1946)|August 26, 1994
[Complete remission in acute promyelocytic leukemia. The advantages of all-trans-retinoic acid compared to conventional chemotherapy]E Lengfelder, M Simon, D Haase, et al.Blood|May 23, 2001
Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-alphaM Schmidt, A Hochhaus, A Nitsche, et al.Cytopathology : Official Journal of the British Society for Clinical Cytology|June 19, 2007
Diagnostic accuracy of cytology and immunocytology in carcinomatous effusionsG Metzgeroth, C Kuhn, B Schultheis, et al.Medizinische Klinik (Munich, Germany : 1983)|June 22, 1999
[The 8p11 myeloproliferative syndrome]A Reither, R Hehlmann, J M Goldman, et al.Expert Opinion on Pharmacotherapy|October 5, 2001
AraC-based pharmacotherapy of chronic myeloid leukaemiaA Reiter, A Hochhaus, U Berger, et al.Chemosphere|May 10, 2008
Atmospheric concentrations of PCDDs/PCDFs in Metropolitan Hartford Connecticut--current levels and historical dataGary T HuntPageof 72